Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Oxford Biomedica (OXB) Share News

IN BRIEF: Oxford BioMedica launches lentiviral vector system

15th May 2023 10:12

Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy group - Launches its 4th generation lentiviral vector delivery system, TetraVecta. Says the TetraVecta system enhances the development of more effective lentiviral vector-based therapies. Firm says this enables cell and gene therapy companies to overcome previous barriers in therapeutic development. Read More

Oxford BioMedica swings to full-year loss amid lower volumes

25th Apr 2023 11:34

(Alliance News) - Oxford BioMedica PLC on Tuesday reported a drop in annual revenue and swung to a loss, as a result of lower volumes and higher costs. Read More

UK earnings, trading statements calendar - next 7 days

13th Apr 2023 15:47

SUMMARY: London listings with exposure to Silicon Valley Bank

13th Mar 2023 12:18

(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: Oxford BioMedica confirms start date of Mathias as new CEO

20th Feb 2023 08:45

Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy group - Says Frank Mathias, previously announced as the company's new chief executive officer, will officially join the firm on March 27. Mathias joins Oxford Biomedica from Rentschler Biopharma SE, where he has been CEO since 2016. Read More

IN BRIEF: Oxford Biomedica subsidiary signs deals with three US firms

14th Dec 2022 10:25

Oxford Biomedica PLC- Oxfordshire, England-based gene and cell therapy group - Says subsidiary Oxford Biomedica Solutions LLC has signed agreements with three unnamed US biotechnology firms. Under the agreements, the subsidiary will provide its full platform offering to support the new partners' pre-clinical gene therapy programmes. Read More

LONDON BRIEFING: UK inflation in November cools off record high

14th Dec 2022 07:53

(Alliance News) - Stocks in London are set to open lower on Wednesday, ahead of a key interest rate decision by the US Federal Reserve later in the day. Read More

IN BRIEF: Oxford BioMedica appoints Frank Mathias as new CEO

22nd Nov 2022 10:15

Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy group - Appoints Frank Mathias as chief executive officer and board director, effective March 2023. Read More

Oxford BioMedica sells Windrush court facility for GBP60 million

14th Nov 2022 14:04

(Alliance News) - Oxford BioMedica PLC announced on Monday it had exchanged contracts for the sale and leaseback of its Windrush Court facility to Kadans Science Partner for GBP60 million. Read More

SMALL-CAP WINNERS & LOSERS: ME Group upgrades outlook on robust demand

14th Nov 2022 11:22

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday. Read More

LONDON BROKER RATINGS: Numis cuts Kingfisher but raises Next

11th Oct 2022 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday: Read More

SMALL-CAP WINNERS & LOSERS: Superdry swings to profit; Halfords falls

7th Oct 2022 11:04

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday. Read More

Oxford Biomedica extends Oaktree relationship with new loan facility

7th Oct 2022 10:30

(Alliance News) - Oxford Biomedica PLC on Friday said that it has completed the partial repayment and amendment of its Oaktree Capital Management LP loan facility, as it looks to extend its relationship with the US banking company further. Read More

SMALL-CAP WINNERS & LOSERS: Capita buoyed by contract win and disposal

16th Sep 2022 10:51

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday. Read More

Oxford BioMedica swings to interim loss as costs climb, revenue falls

15th Sep 2022 10:16

(Alliance News) - Oxford BioMedica PLC on Thursday reported a swing to interim loss and a decline in interim revenue. Read More

IN BRIEF: Oxford BioMedica subsidiary signs deal with new partner

14th Sep 2022 09:57

Oxford BioMedica PLC - Oxford, England-based gene and cell therapy company - Says subsidiary Oxford Biomedica Solutions LLC has signed a deal with an unnamed new partner, for an undisclosed sum. Says the deal gives the US-based, private biotechnology firm access to Oxford BioMedica Solutions's process and manufacturing platform. Read More

FTSE 100 Latest

Value10,901.09

Change0.00